Chicoâs FAS Inc. (NYSE: CHS)Â
Phunware Inc. (NASDAQ: PHUN)Â Invo Bioscience Inc.Â
Shares of the biotech company shot up late in the session on Monday. Before we get into why letâs take a closer look at Invo Bioscience. The company produces medical devices used in the treatment of infertility in women. This includes its INVO Procedure, which is a more natural way to perform incubation. Its leading product, known as INVOcell, is a patented device known as an Assisted Reproductive Technology or ART. It is an intravaginal culture system and can inseminate eggs for embryo development. This is an alternative to traditional in-vivo procedures and can be much more cost-effective and available for patients.
INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U S Commercialization Agreement
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U S Commercialization Agreement
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
INVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico
News provided by
Share this article
SARASOTA, Fla., March 1, 2021 /PRNewswire/
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world s only in vivo Intravaginal Culture System (IVC), INVOcell
®, an effective and affordable treatment for patients diagnosed with infertility, today announced the Company has received approval by COFEPRIS to import INVOcell into Mexico. In late 2020, INVO Bioscience established a joint venture focused on establishing fertility centers dedicated to offering INVOcell, with the initial center, called Positib Fertility, to be located in the city of Monterrey, Mexico.
AMNM successfully performs invasive fertility surgery in Qatar
28 Feb 2021 - 9:53
A view of an inpatient room at Alfardan Medical with North-western Medicine.
The Peninsula
Doha: Alfardan Medical with Northwestern Medicine (AMNM), Qatar’s renowned and medically advanced ambulatory care center, recently conducted an innovative fertility preserving operation to remove a uterine polyp, which is usually associated with infertility, heavy menstruation, and anaemia.
The surgical procedure was performed for the first time in Qatar by AMNM’s Reproductive Medicine Physician and Gynaecologist, Dr. Guy Fender to minimize the surgical impact on the cervix and the uterine lining.
The minimally invasive technique used increases spontaneous and In vitro Fertilization (IVF) treated pregnancy success and reduces the risk of premature delivery. The value of this approach allows surgeons to avoid damaging the uterine lining caused by traditional techniques which are associated with ther